Niki BioSolutions NIKI

Niki BioSolutions amends registration statement for securities offering

Securities offering (amended)

Form
S-3/A
Filed
Importance
Routine
  1. Amends registration statement for securities offering
  2. Updates disclosure on legal and operational risks in Hong Kong
  3. Plans to offer up to $75M in securities

Written from the S-3/A on EDGAR. Check the filing before you rely on it.

Get an email when Niki BioSolutions files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 3829 and related industry codes: the same peer list as the financial tables.